spot_img
12.9 C
London
HomeInvestors HealthBiora Therapeutics granted extension to regain compliance with Nasdaq

Biora Therapeutics granted extension to regain compliance with Nasdaq


  • Biora Therapeutics (NASDAQ:BIOR) has announced that the company has been granted an extension to regain compliance with Nasdaq listing requirements.
  • “We shared with Nasdaq the upcoming company catalysts that we believe will drive significant value for shareholders, and we are pleased with their decision to grant us an extension to regain compliance,” said Adi Mohanty, CEO.



Source link

latest articles

explore more

LEAVE A REPLY

Please enter your comment!
Please enter your name here